Glomerular cell proliferation and PDGF expression precede glomeru. losclerosis in the remnant kidney model. Increasing evidence supports a role of glomerular cell proliferation in the development of focal or diffuse glomerulosclerosis. This study investigates the chronology and sequence of cellular events that precede glomerulosclerosis in 5/6 nephrectomized rats. Within three days of renal ablation, a phenotypic switch occurred in which some mesangial cells expressed a-smooth muscle actin. This was followed by proliferation of mesangial cells, and to a lesser degree endothelial cells from day 5 to week 4 as detected by immunostaining for the proliferating cell nuclear antigen (PCNA).
In addition to these proposed mechanisms there is increasing evidence that mesangial cell proliferation may also be important in the pathogenesis of mesangial expansion and the development of focal or diffuse glomeruloscierosis. Thus, correlations between mesangial or glomerular cell proliferation and subsequent development of sclerosis have been noted in minimal change disease progressing to focal sclerosis in humans [17] , in 3/4 nephrectomized rats [18] and in the anti-Thy 1.1 model of mesangial proliferative glomerulonephritis in rats [19, 20] .
Moreover, in some models platelet depletion can reduce mesangial cell proliferation [21, 22] , and treatment with anti-platelet agents and non-anticoagulant heparin derivatives with antiproliferative activity also reduce glomerulosclerosis [23] [24] [25] [26] [27] .
The precise mechanism(s) that lead to the proliferation of glomerular cells in vivo are incompletely understood. Possibilities include a mesangial cell response to growth factors derived from platelets [23, 27] , macrophages [1, 9, 11, 14] and endothehal cells [101 or direct activation by deposited macromolecules [1, 7, 9, 10] , lipids [15, 16] or circulating or locally released glomerular hypertrophic factors [1, 8] . In this context PDGF is one of the most potent mesangial cell mitogens in vitro, and it can be released not only from activated platelets, but also from macrophages, endothelial cells and mesangial cells themselves [28] [29] [30] [31] [32] . Recently, we have obtained evidence supporting a role for PDGF in the induction of mesangial cell proliferation following immune injury in vivo [33] .
To clarify the factors involved in the induction of glomerular cell proliferation as they relate to development of sclerosis in a non-immune model of progressive renal disease, we have is associated with increased glomerular PDGF and PDGF receptor expression; and (4) relate these events to the later development of proteinuria and glonierular sclerosis.
Methods
Disease model and experimental protocol Seventy male Sprague-Dawley rats (Simonson, Gilroy, California, USA) weighing 140 to 160 g at the start of the experiment were studied. Animals were fed standard rat chow (Wayne Rodent Blox, Animal Specialty, Hobart, Oregon, USA). In 35 rats (OP group) a right subcapsular nephrectomy and infarction of approximately two-thirds of the left kidney was accomplished by ligation of the posterior and 1 or 2 anterior extrarenal branches of the main renal artery under equithesin anesthesia (1% sodium pentobarbital, Anthony Products, Arcadia, California, USA; 4.25% chloral hydrate, Spectrum Chemicals, Gardena, California, USA; 0.3 ml/100 g body wt). In the control group (SHAM) of 35 rats, a sham operation consisting of laparotomy and manipulation of the renal pedicles but without destruction of renal tissue was performed. Postoperative 24-hour urinary protein excretion and serum creatinine values were determined at days 3 and 5 as well as at weeks 1, 2, 3, 4, 7.5 and 10 in 8 to 10 randomly selected animals of both groups. At each time point five rats from each group underwent renal biopsy (no rat underwent more than one biopsy). At 10 weeks the surviving rats (31 of the OP group and 35 of the SHAM group) were sacrificed and further renal tissue specimens were obtained. In all cases cortical biopsies were taken from the center of the non-infarcted area only. Biopsies were studied to quantitate and localize total and proliferating glomerular cells, monocyte/macrophages, neutrophils, lymphocytes, mesangial cells, and cells expressing a-smooth muscle actin, PDGF B-chain, PDGF receptor /3-subunit and fibnnogen. In addition, a separate experiment was performed to quantify intraglomerular platelet accumulation at day 5 (10 operated and sham operated rats) and weeks 2 and 4 (5 operated and sham operated rats each) by the i.v. injection of 'In-labelled platelets. Finally, RNA was extracted from isolated glomeruli of operated and sham operated rats at day 5 and week 2. Northern analysis was performed using cDNA probes specific for PDGF receptor a-and p-subunits.
Renal morphology
Tissue for light microscopy and immunoperoxidase staining was fixed in methyl Carnoy's solution [211 and embedded in paraffin.
Three m sections were stained with the periodic acid Schiff (PAS) reagent and hematoxylin. The percentage of glomeruli exhibiting focal or global glomeruloscierosis was determined. Glomeruloscierosis was evidenced by segmental increases in glomerular matrix, segmental collapse and obliteration of capillary lumina and accumulation of hyaline, and frequently was associated with synechial attachments to Bowman's capsule. Less commonly, these lesions also were associated with prominence of visceral epithelial cells, and intracapillary microthrombosis. Total glomerular cellularity was evaluated by counting the total number of nuclei per glomerular cross section. All glomerular cross sections present in a specimen were evaluated. Sections of the glomerular tuft, in which the cross sections had a very low cellularity (arbitrarily defined as < 50 cells/cross section), which are likely to represent tangential sections, were excluded from the analysis.
Electron microscopy
Tissue for electron microscopy was fixed, processed and examined as described previously [34] . Ultrastructural studies were performed on two specimens each obtained at days 3 and 5 and week 1 after 5/6 nephrectomy (8, 10 and 9 glomeruli, respectively, were evaluated in these specimens). Furthermore, electron microscopy was performed on two specimens obtained at day 3 and week 1 after sham operation (8 and 10 glomeruli evaluated, respectively).
Immunohistochemistry
Four tm sections of methyl Carnoy's fixed biopsy tissue were processed by an indirect immunoperoxidase technique or an indirect immuno-alkaline phosphatase method (PDGF B-chain) as previously described [21, 33] . Primary antibodies included:
-19A2 (American Biotech Inc., Plantation, Florida, USA), a murine 1gM monoclonal antibody against human PCNA, which is expressed by actively proliferating cells. Nuclear expression of PCNA is absent in the G0 and early G1 phase of the cell cycle and increases in the late G1 and S phase, followed by a decrease in G2/M [35] . -EDt (Bioproducts for Science, Indianapolis, Indiana, USA), a murine monoclonal IgG to a cytoplasmic antigen present in monocytes, macrophages and dendritic cells. -RP-3 (gift of F. Sendo, Yamagata, Japan), a murine monoclonal antibody to rat neutrophils [361.
-OX-22 (Accurate Chemical Corporation, Westbury, New York, USA), a murine monoclonal antibody to the high molecular weight form of the common leukocyte antigen expressed on B-lymphocytes and most T-lymphocytes. -PGF-007 (Mochida Pharmaceutical, Tokyo, Japan), a murine monoclonal antibody to a 25 amino acid peptide located near the COOH-terminus of the human PDGF B-chain [37] . -a rabbit polyclonal antibody to the /3-subunit of the PDGFreceptor as described elsewhere [33] . -a murine monoclonal antibody to an NH2-terminal synthetic decapeptide of a-smooth muscle actin (gift of G. Gabbiani, Geneva, Switzerland) [38] .
For all biopsies, negative controls consisted of substitution of the primary antibody with equivalent concentrations of an irrelevant murine monoclonal antibody or normal rabbit IgG. For each biopsy more than 15 consecutive cross sections of cortical glomeruli containing more than 20 discrete capillary segments each were evaluated by a blinded observer and mean values per biopsy were calculated for the number of proliferating (PCNA +) cells, and for the various leukocyte populations. A semiquantitative scoring system described elsewhere [39] was used to grade the glomerular expression of PDGF-B chain (PGF 007 immunoalkaline phosphatase staining). For the evaluation of the immunoperoxidase stains for a-smooth muscle actin and PDGF receptor, each glomerulus was graded semiquantitatively as follows: 
Immunofluorescence staining
Immunofluorescence detection of glomerular fibrinogen was carried out on 4 m sections of frozen kidney tissue using a direct immunofluorescence procedure [40] with an FITC-coupled goat anti-rat fibrinogen antibody (Organon-Teknika/Cappel, Malvern, Pennsylvania, USA). Glomerular cross sections were graded semiquantitatively as either "0" (indistinguishable from control) or positive according to the extent of glomerular fluorescence ("1+" < 25% of the tuft showing fluorescence, "2+" 25 to 50%, "3+" 50 to 75% and "4+" > 75%).
In situ hybridization for PDGF B-chain
In situ hybridization was performed on 4 m sections of biopsy tissue fixed in buffered 10% formalin utilizing a digoxigenin-labelled anti-sense cRNA probe for the murine PDGF B-chain (derived from a cDNA, clone provided by Charles Stiles, Boston) as described [39] . Detection of the cRNA probe was performed with an alkaline phosphatase coupled anti-digoxigenin antibody (Genius Nonradioactive Nucleic Acid Detection Kit, Boehringer-Mannheim, Mannheim, Germany) with subsequent color development. Controls consisted of hybridization with a sense probe to matched serial sections, by hybridization of the anti-sense probe to tissue sections which had been incubated with RNaase A before hybridization, or by deletion of the probe, antibody or color solution [39] . '111n-labelled platelet studies Glomerular platelet localization in control and remnant kidney rats was quantified at day 5 and weeks 2 and 4. Platelets were isolated for labelling from blood (6 ml) collected by cardiac puncture into 1 ml of acid citrate dextrose and 4.2 ml Ringer's citrate dextrose (pH 6.7) was added. Following centrifugation at 250x g for 10 minutes at room temperature the platelet rich plasma was removed and the pH adjusted to 6.7. The platelet rich plasma was then centrifuged at 800X g for 20 minutes at room temperature and the pellet was washed with Ca2Mg2free Hanks Balanced Salt Solution (HBSS), pH 6.7 (Irvine Scientific, Santa Ana, California, USA) and the platelets were collected after centrifugation at 800 g for an additional 20 minutes. The platelet pellet was suspended in 2 ml HBSS, and 30 Ci of "In-oxine (Amersham, Arlington Heights, Illinois, USA) were added. Further incubation and washing steps were performed as described [41] . For each experiment 1 8 "In labelled platelets were infused into a tail vein. Each infusion also contained 0.5 pCi of '251-labelled [41] rat IgG (Miles, Naperville, Illinois, USA) to quantify glomerular blood contamination. One hour after the injection the number of platelets accumulating in glomeruli was determined from the "In and 125j counts measured in blood and isolated glomeruli as described [41, 42] . Total RNA was extracted from isolated glomeruli from three separate groups of 10 operated and four sham-operated rats each with RNAzol B' following the manufacturer's instructions (CinnalBiotecx Laboratories, Friendswood, Texas, USA). The RNA obtained was further purified by an overnight precipitation in 3 M LiCI at -20°C, followed by a 30 minute centrifugation at 4°C and 12,000x g and a final washing step with 75% ethanol. For Northern analysis the RNA was thawed, denatured and 15 tg/lane were electrophoresed through a formaldehyde/agarose gel and transferred to a nylon filter (Hybond N, Amersham) as described [34] . The cDNA probes used for
Northern analysis were as follows:
1) PDGF receptor a-subunit. A 7 and a 4.5 kb EcoRI fragment of rat PDGF a-receptor cDNA from plasmid p802E [43] was used for the detection of the 6.7 kb rat PDGF a-receptor transcript. Membranes were prehybridized and hybridized as described
[341 and autoradiograms were obtained and read by linear densitometry [34] . All Northern analyses were repeated two to three times with glomerular RNA preparations obtained from different sets of animals. Some membranes were rehybridized with additional probes (up to a maximum of 4x) [34] .
Quantitation of PDGF receptor mRNA Glomerular mRNA levels for pools of 10 remnant kidneys or four control kidneys were quantified by slot-blot analysis prepared with 2, 1 and 0.5 tg of each RNA sample and control RNAs. Aliquots were applied to wells of a slot-blot manifold (Schleicher & Schuell, Keene, New Hampshire, USA) and blotted onto nylon filters (Nytran', Schleicher & Schuell) under vacuum. Fixation, prehybridization, hybridization and washing conditions were identical with those used for Northern analysis. Autoradiograms were then obtained and read by linear densitometry. Densitometry readings were normalized for equivalent amounts of 28S ribosomal RNA per lane as described [34] . Values are expressed as optical density units relative to the specific mRNA level observed in glomerular RNA from normal rats.
Miscellaneous measurements
Serum creatinine was measured using picric acid (Worthington Diagnosis, Freehold, New Jersey, USA) and urine protein excretion was measured by a sulfosalicylic acid method [45] using a whole serum standard (Lab Trol, Dade Diagnostics, Aquado, Puerto Rico). Statistical analysis All values are expressed as mean SD unless stated otherwise. Statistical significance (defined as P < 0.05) was evaluated using the Student's t-test or one way analysis of variance with modified i-tests performed using the Bonferroni correction [46] .
Results
Glomerular expression of a-smooth muscle acrin precedes the onset of proliferation Glomerular expression of a-smooth muscle actin was the only variable studied which antedated the onset of glomerular cell proliferation in the OP-group: while glomerular staining in sham operated animals was either absent or confined to the base of the glomerular tuft (Fig. lA,C) , small areas of glomerular staining were noted in 5/6-nephrectomized animals three days after the operation (Fig. IC) . At all later time points, staining for a-smooth muscle actin remained significantly elevated in the OP-group (Fig. lB,C) .
Glomerular cell proliferation starts five days after renal ablation
PCNA staining revealed that glomerular cell proliferation had begun within five days of renal ablation and peaked at week 2 ( Fig. 2) . Thereafter proliferation slowly subsided but remained above controls throughout the 10 weeks of the study. Total 10 glomerular cellularity was not significantly increased until two weeks after ablation and continued to increase thereafter (Fig.  2) . In contrast, controls showed no increase in total or proliferating glomerular cells over the study period (Fig. 2) .
Glomerular leukocyte infiltration follows cell proliferation Figure 3 shows that glomerular localization of ED1-positive monocytes/macrophages remained in the normal range at the onset of glomerular cell proliferation with the first significant increase occurring between week 1 and 2. Thereafter a slow, continuous glomerular influx of monocyte/macrophages occurred until 7.5 weeks following 5/6 nephrectomy. A further increase of glomerular monocytes/macrophages was noted at week 10 ( Fig. 3) . In contrast, glomerular neutrophil counts and OX-22 positive B-or T-lymphocyte counts in the OP-group remained within the normal range of 0.4 0.2 (neutrophils; RP-3) and 0. 0.
(0 a)
0. biopsies obtained in control rats at day 3 and at week 10; data not shown). Following 5/6 nephrectomy the number of proliferating mesangial cells increased 9.2-or 7.9-fold, respectively, at weeks 1 and 2 and then returned to the normal range at week 10 ( Table 1) . Proliferating non-mesangial cells in the glomeruli of 5/6 nephrectomized rats also increased transiently by 2.7-fold at week 1 (Table 1) . Since a significant glomerular influx of either neutrophils or lymphocytes was excluded at these time points (see above), these proliferating non-mesangial cells presumably represented monocyte/macrophages, podocytes, or endothelial cells.
To identify the proliferating non-mesangial cells, double immunostaining was performed with antibodies against PCNA and the ED1 antigen present on monocyte/macrophages, since these cells can still undergo one cell-cycle after extravasation [47, 48] . The results demonstrated that monocytes/macrophages did not contribute to the early 2.7-fold increase of proliferating non-mesangial cells noted at week 1: at any time point up to week 4 proliferating monocytes/macrophages were within the normal range in the OP-group (Table 1) . In contrast, at weeks 7.5 and 10 the number of proliferating monocytes/ macrophages per glomerular cross section increased significantly in the OP-group (Table 1) . At week 10 proliferating monocyte/macrophages accounted for the majority of proliferating glomerular cells (Table 1) . 
Glomerular platelet influx but not intraglomerularfibrinogen deposition coincides with the onset of glomerular cell proliferation
Quantification of intraglomerular platelets using '1In-labelled platelets showed a significant (P < 0.02 vs. SHAM) increase at day 5 in the OP-group (Table 2) . Gbomerular platelet counts in the OP-group remained elevated in comparison to sham-operated animals at week 2 and increased further at week 4 after 5/6 nephrectomy ( Table 2) . Table 2 also shows that no increase in glomerular fibrinogen deposition was detectable at day 3 in the OP-group. Also no increase was noted at day 5, when glomerular cell proliferation had already started. At all later time points the glomerular fibrinogen content was significantly elevated in the OP-group (Table 2) . Glomerular PDGF B-chain and PDGF receptor gene and protein expression increase during glomerular cell proliferation The glomerular expression of PDGF B-chain mRNA and protein paralleled the course of glomerular cell proliferation. As shown in Figure 4A -C, the glomerular immunohistochemical staining for PDGF B-chain protein in the OP-group was not different from sham controls at day 3 but increased significantly between weeks 1 to 7.5. No significant difference remained at week 10. At week 2 after 5/6 nephrectomy Strong immunohistochemical staining mainly localized to the cytoplasm of cells within the glomerular tuft, although occasional, weaker staining was also noted in the cytoplasm of cells in podocyte locations (Fig. 4C) . In situ hybridization for glomerular PDGF B-chain mRNA also demonstrated increased glomerular localization in operated animals between weeks 1 and 4 ( Fig. 5B) , while no glomerular staining was present in sham-operated rats or in biopsies of the OP-group obtained at day 3, day 5, or week 10 ( Fig. 5A,C) . The immunohistochemical staining for PDGF receptor 13-subunit increased after the onset of glomerular cell proliferation in OP-rats with the first significant difference compared to the SHAM group occurring at week 2 (Fig, 4A,D,E) . Increased PDGF-receptor staining in a strongly mesangial pattern then persisted at all subsequent time points examined in the OPgroup (Fig. 4A,D,E) . Northern analysis of total glomerular RNA isolated from either 5/6 nephrectomized or sham operated rats showed the presence of a typical 5.7 kb PDGF receptor (3-subunit transcript in both groups (Fig. 6 ). Densitometric quantification of mRNA levels by slot-blot analysis revealed a 1.4 0.1-fold increase (N = 3) of PDGF receptor 13-subunit mRNA expression at week 2 in the OP-group, while no such difference between operated and sham-operated rats was noted at day 5. Expression of glomerular PDGF receptor a-subunit mRNA could not be demonstrated by Northern analysis in either group (data not shown).
Temporal relationship of glomerular ultrastructural abnormalities to glomerular cell proliferation Electron microscopy performed on specimens obtained at days 3 and 5 and week 1 after 5/6 nephrectomy showed protein reabsorption droplets in glomerular epithelial cells as early as day 3. The number of protein reabsorption droplets then gradually increased with time (Fig. 7A) . No evidence of gbmerular epithelial cell damage such as foot process effacement or fusion was noted during the first week in the OP-group. Most of the glomerular endothelial cells in operated rats showed a normal ultrastructure, although endothelial cell swelling was observed occasionally. The mesangium of operated rats appeared normal prior to week 1. At week 1 occasional mesangial hypercellularity and prominent mesangial channels, possibly reflecting minor mesangiolysis, were present (Fig. 7B) . Also, at week 1 rare intracapillary platelet accumulations were noted. In the specimens examined only one focus of fibrin tactoid accumulation was present at week 1 in the OP-group in the urinary space, while no fibrin clots were detectable within the capillary lumina.
Progressive renal insufficiency, proteinuria and glomeruloscierosis develop after the onset of glomerular cell proliferation
Following the 5/6 nephrectomy, an immediate rise of serum creatinine occurred in the rats of the OP-group (Table 3) . Serum creatinine then remained stable in this group until week 4 after which a continuous further rise was noted (Table 3) . Pathological proteinuria (defined as >25 mg/24 hr) was present in the rats of the OP-group after week 2 ( Table 3 ). SignifIcant light microscopic changes of focal or diffuse glomerulosclerosis, as described in the methods section, were absent at day 3 and week 1 after the operation and gradually increased thereafter in the OP-group (Table 3) .
Discussion
The first discernible pathological change we observed following 5/6 nephrectomy was the intraglomerular expression of a-sffiooth muscle actin. We have recently shown that the glomerular expression of a-smooth muscle actin, which in the normal mature rat kidney is expressed only by vascular smooth muscle cells, reflects a mesangial cell phenotypic switch associated with the induction of proliferation [34] . The observation that glomerular a-smooth muscle actin expression in 5/6 nephrectomized rats preceded detectable proliferation suggests that mechanisms different from those that initiate proliferation might be operative in the regulation of this actin isoform. One such mechanism may be the rapid increase in glomerular capillary pressure, GC, which occurs following 5/6 nephrectomy [49] and which is transmitted to mesangial cells. However, the earliest timepoint after 5/6 nephrectomy at which P0 has been measured was one week [49] (at which time point it was found to be elevated), and consequently it is possible that glomerular pressures were not increased at three and five days. Thus, we cannot exclude the possibility that non-hemodynamic factors, such as humoral mediators [8] , may be responsible for the early changes observed after 5/6 nephrectomy.
Five days after renal ablation, an abrupt increase in proliferating cells in the glomerulus was observed, which preceded significant proteinuria and glomerular sclerotic changes by one to two weeks. Previous investigators have suggested that mesangial cell proliferation may be responsible for this hypercellularity [49, 50] , but no direct evidence or quantitative data have been provided. Double immunostaining in the present study confirmed that most of the proliferating cells at one to two weeks were indeed mesangial cells. A similar proliferation of cells predominantly in a mesangial localization at 72 hours or two weeks following 3/4 nephrectomy has also been detected in the remnant kidney model by autoradiographic studies [18, 51] . We also found that non-mesangial proliferating cells increased significantly at one to two weeks. Since these cells were not infiltrating leukocytes and are unlikely to be epithelial cells [this study and 18, 51, 52] it seems probable that they represented endothelial cells, which in normal rats account for 70 to 80% of the spontaneously proliferating cells [53] . Two previous autoradiographic studies in 3/4 nephrectomized rats showed proliferating cells in endothelial cell locations [18, 51] , although it was not documented that proliferation of endothelial cells in fact increased after renal ablation.
Previous studies in a model of hypertensive small vessel injury have demonstrated that increases in pressure within capillaries can cause endothelial cell injury and platelet accumulation [54] . However, in the present study, despite a presumed rapid increase in glomerular capillary pressure P, there were few ultrastructural indications of glomerular cell damage prior to, or at the time of, the induction of proliferation. In contrast to the lack of significant ultrastructural evidence for glomerular endothelial or epithelial damage, rare intracapillary platelet accumulations were detected one week after 5/6 nephrectomy in a minority of glomeruli, suggesting that the increased shear stress in the glomerular capillaries of these rats led to alterations of the antithrombotic properties of the capillary walls.
In the present study glomerular platelet accumulation, but not thrombus formation (as evidenced by fibrinogen deposition), occurred at the same time point as the onset of glomerular cell proliferation. Although the average glomerular platelet accumulation was small compared to other models [41, 42] and only correlated with the onset but not with the termination of glomerular cell proliferation, our findings support the hypothesis that glomerular platelet influx may be of pathogenetic significance in the remnant kidney model. Platelets and intraglomerular coagulation have long been implicated in the development of glomerular sclerosis in the renal ablation model [1, 3, 50] . Electron microscopic studies have repeatedly demonstrated the presence of platelets and thrombi in glomerular capillaries of rats with extensive renal mass ablation [3, 6, 50] . Glomerular thrombus formation and capillary obsolescence have been regarded as the principal consequences of platelet accumulation. However, another way in which platelets may contribute to glomerulosclerosis is by releasing TGF-/3, which has recently been shown to contribute to matrix accumulation in a rat model of mesangioproliferative glomerulonephritis [55, 56] . These proposed roles for glomerular platelet accumulation and coagulation have received support from a number of pharmacological intervention studies. It has been shown that treatment with different thromboxane synthase inhibitors, which have potent anti-platelet actions, ticlopidine, which non-selectively inhibits several stimuli leading to platelet activation, or anticoagulants such as heparin and warfarin are all able to retard the progression of glomeruloscierosis in the remnant kidney model [23, 24, 27] . On the other hand, treatment with a different TxA2 antagonist [251 or low dose aspirin [57] , which suppresses TxA2 dependent platelet aggregation but not collagen-induced platelet degranulation [581, did not offer any protection in this disease model. This indicates that other platelet related mechanisms might also be of importance in the progression of renal disease. Furthermore, N-desulfated/acetylated heparin, which completely lacks anticoagulant but retains antiproliferative activity was nearly as protective as regular heparin in 5/6 nephrectomized rats [26] .
Apart from thrombus formation and release of substances involved in matrix overproduction, such as TGF-f3, another important role of platelets in glornerular diseases is the release of growth factors potentially mediating glomerular cell proliferation. Such platelet-derived mitogens include PDGF, TGF-cxl EGF, TGF-/3 in low concentrations as well as a recently described endothelial cell growth factor [29] [30] [31] 59, 601. Indeed,  in vivo studies have shown that mesangial cell proliferation in the Habu snake venom and the anii-Thy 1.1 model of mesangioproliferative glomerulonephritis is mediated by platelets [21, 221.
The primary mitogen for cultured mesangial cells released from activated platelets is PDGF [29] [30] [31] [32] 59] . Apart from platelets, PDGF A-and B-chains can also be produced by a variety of other cells, including the mesangial cells themselves [29] , endothelial cells [61] and macrophages [281. An in vivo role for PDGF in states of mesangial proliferation has been suggested by the observations of increased glomerular PDGF mRNA and protein expression in the anti-Thy 1.1 model of mesangioproliferative glomerulonephritis [33, 39] as well as in a mouse model of mesangial nephropathy [62] . Confirmation of these hypotheses will require studies in which the effect of selective PDGF blockers can be evaluated. Such studies are now in progress. However, these findings suggest that plateletinduced glomerular cell proliferation may become self-perpetuating by an autocrine mechanism involving mesangial cell production of PDGF. This concept of separate roles for PDGF in initiation and maintenance of mesangial cell proliferation is supported by the present study which shows that a detectable increase in glomerular PDGF B-chain mRNA was first found 48 hours after the onset of proliferation and that thereafter the gene and protein expression of PDGF B-chain was closely correlated with the course of glomerular cell proliferation.
The cellular source of the increased PDGF mRNA expression is likely to involve mesangial [29] as well as endothelial cells [61] but not macrophages, which accumulated in the glomeruli mainly at later stages. Our observation of immunostaining for PDGF B-chain in occasional cells in podocyte locations would suggest that these cells too may have contributed to the increased glomerular expression of PDGF B-chain mRNA. However, PDGF production by glomerular epithelial cells has not been described. With respect to the mitogenicity of PDGF for glomerular cells, in vitro data have shown that mesangial In contrast to PDGF, which presumably either alone or in combination with other, yet unidentified mitogens was responsible for the maintenance of proliferation in the present study, the nature of the stimulus responsible for the initiation of proliferation remains much more speculative. Possible candidates include mitogens released from activated platelets [28] [29] [30] [31] [32] 59 ], shear stress-induced release of endothelial cell PDGF [61] , or bFGF [29] or yet unknown circulating "renotropins" [64] .
Simultaneous with the increase of glomerular PDGF expression, increased immunohistochemical staining for the PDGF receptor /3-subunit was noted in the mesangium of 5/6 nephrectomized animals. In contrast, glomerular PDGF receptor 13-subunit nRNA only showed a low grade increase. This later finding may result from a combination of factors, including the inhomogenous glomerular involvement during the disease and the fact that mesangial cells, that is, the main glomerular cells likely to express PDGF receptors, only account for about 30% of the glomerular cells. Furthermore, in a hypertrophied glomerulus the cellular mRNA content will increase, implying that if 15 g RNA is loaded per lane during Northern analysis this will correspond to fewer cells than in control rats. Alternatively, the discrepancy between the marked increase in PDGF receptor immunostaining and the minor increase of PDGF receptor gene expression could be due to post-transcriptional regulation of the PDGF receptor expression. In the absence of reliable quantitative data, it therefore remains speculative whether the increased receptor protein and gene expression was merely a reflection of the increase in mesangial cell numbers or whether it did represent receptor overexpression. On the other hand our findings demonstrate that total glomerular PDGF-receptor numbers increase not only during glomerular inflammation, as suggested by earlier studies [33, 65] , but also in non-inflammatory diseases such as the renal ablation model.
The last event in the chronology of pathological findings observed in the present study was a glomerular influx of monocyte/macrophages, which occurred in parallel with the onset of significant proteinuria and sclerotic changes. This finding suggests that mesangial cell proliferation is not causatively related to factors released by macrophages. Rather, the glomerular monocyte/macrophage influx appears to be a secondary reaction. The late mononuclear cell infiltrate could be driven by the release of chemoattractant factors such as PDGF [1] , glomerular complement activation, the release of monocyte chemoattractant peptide (MCP-1/JE-protein) [66] , or migration inhibitory factor [67, 68] from activated endothelial cells or of a recently described mesangial cell chemoattractant [69] from the damaged glomerulus. If glomerular monocyte/macrophage influx is viewed as a response to the early glomerular damage including glomerular cell proliferation (that is, related to the severity and extent of damage) this may explain why glomerular macrophage numbers have been found to correlate with the development of focal and segmental glomeruloscleosis in the renal ablation model [18] .
Based on the present findings and previous observations, we suggest the following sequence of pathogenetic events in the glomerulopathy that occurs in rats with severe renal ablation ( Fig. 8) : Following extensive loss of renal mass the resulting non-hemodynamic and/or adaptive hemodynamic changes, including a rise in glomerular capillary pressure and shear stress, induce a mesangial cell phenotype switch and activation, as evidenced by the glomerular expression of a-smooth muscle actin. Also, as a consequence of increased shear stress on the endothelium, the antithrombotic properties of the capillary wall may be altered. These glomerular alterations in turn facilitate the glomerular localization and activation of platelets. Platelet release products may constitute the "initiator signal" for mesangial (and endothelial) cell proliferation. Alternatively, the "initiator signal" may be derived from circulating humoral factors or mitogens derived from intrinsic glomerular cells. Subsequently, mesangial and endothelial cell proliferation becomes self-perpetuating by the endogenous production of mesangial (and endothelial) cell PDGF in the presence of increased glomerular PDGF receptor expression. Secondary to the mesangial cell proliferation, matrix overproduction and glomerular macrophage influx occur, both of which correlate with the later development of glomerular sclerotic changes. This theoretical model may provide a rationale for further intervention studies specifically addressing the role of platelets and/or PDGF in progressive renal disease.
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